Webinar on CMS and Affordable Care Act:First of a series of AMCP Member Regulatory Briefings providing an overview of newly proposed regulations and agency guidance relevant to managed care pharmacy Watch RecordingClose
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.
Host Fred Goldstein discusses current biologic options and the impact to the Immunology Market landscape with Michael Rothrock MHA, MBA, and Chronis H. Manolis, RPh.
2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.